search
Back to results

The Effect of Dexamethasone in Combination With Paracetamol and Ibuprofen on Postoperative Pain After Spine Surgery

Primary Purpose

Pain

Status
Completed
Phase
Phase 4
Locations
Denmark
Study Type
Interventional
Intervention
Dexamethasone
Placebo
Morphine
Zofran
Paracetamol
Ibuprofen
Sponsored by
Rigshospitalet, Denmark
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pain focused on measuring Pain, Analgesia, Postoperative, Dexamethasone, Spine surgery

Eligibility Criteria

18 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients undergoing lumbar disc surgery in general anaesthesia.
  • Patients who have given their written consent to participate and understand the contents of the protocol.
  • ASA 1-3.
  • BMI > 18 og < 40.
  • Fertile women need a negative HCG urine test.

Exclusion Criteria:

  • Patients who cannot cooperate to the study.
  • Patients who do not speak and/or understand Danish.
  • Fertile women with a positive HCG urine test.
  • Allergy to the drugs used in the trial.
  • Alcohol or medicine abuse, assessed by investigator.
  • Patients who have had spine surgery before.
  • Daily use of strong opioids (morphine, ketobemidone, oxynorm, methadone, fentanyl)
  • Daily oral steroid treatment.

Sites / Locations

  • Glostrup University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

Dexamethasone

Placebo

Arm Description

Intravenous administration of dexamethasone 16 mg (concentration 4 mg/ml, volume 4 ml) immediately after endotracheal intubation Morphine. Patient controlled intravenous morphine (PCA-pump), bolus 2.5 mg, lock-out-time 10 minutes. Concentration : Morphin 1 mg/ml. Zofran 4 mg iv in case of moderate to severe nausea, supplemented by Zofran 1 mg iv if needed Tablet Paracetamol 1 g orally and tablet Ibuprofen 400 mg orally. Both 1 hour preoperatively and every 6 hours after extubation time during the first 48 hours.

Intravenous administration of isotonic sodium chloride (concentration 9 mg/ml, volume 4 ml) immediately after endotracheal intubation Morphine. Patient controlled intravenous morphine (PCA-pump), bolus 2.5 mg, lock-out-time 10 minutes. Concentration : Morphin 1 mg/ml. Zofran 4 mg iv in case of moderate to severe nausea, supplemented by Zofran 1 mg iv if needed Tablet Paracetamol 1 g orally and tablet Ibuprofen 400 mg orally. Both 1 hour preoperatively and every 6 hours after extubation time during the first 48 hours.

Outcomes

Primary Outcome Measures

Painscore during mobilization
Painscore during active mobilization (VAS scale) defined by a standarized movement from recumbent position to sitting on the bedside at time 2, 4, 8, 12 and 24 hours, calculated as area under curve (AUC) from 2-24 hours after extubation time.

Secondary Outcome Measures

Painscore during rest
Painscore during rest (VAS scale) at time 2, 4, 8, 12 and 24 hours, calculated as area under curve (AUC) from 2-24 hours after extubation time.
Morphine consumption
Total morphine consumption 0-24 hours after extubation time, administered as patient controlled analgesia (PCA, bolus 2.5 mg, lockout 10 minutes).
Painscore during rest and mobilization
Painscore during rest and during active mobilization (VAS scale) at time 48 hours after extubation time.
Degree of nausea
Degree of nausea 2, 4, 8, 12, 24 and 48 hours after extubation time
Incidence of vomiting
Total number of vomits 0-2, 2-4, 4-8, 8-12, 12-24 and 24-48 hours after extubation time.
Zofran consumption
Consumption of Zofran (milligram) 0-24 and 24-48 hours after extubation time.
Degree of sedation
Degree of sedation 2, 4, 8, 12, 24 and 48 hours after extubation time.
Quality of sleep
Quality of sleep 24 hours after extubation time.

Full Information

First Posted
September 26, 2013
Last Updated
October 26, 2015
Sponsor
Rigshospitalet, Denmark
Collaborators
Glostrup University Hospital, Copenhagen
search

1. Study Identification

Unique Protocol Identification Number
NCT01953978
Brief Title
The Effect of Dexamethasone in Combination With Paracetamol and Ibuprofen on Postoperative Pain After Spine Surgery
Official Title
The Effect of Dexamethasone in Combination With Paracetamol and Ibuprofen as Adjuvant, Postoperative Pain After Herniated Disc Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
October 2015
Overall Recruitment Status
Completed
Study Start Date
December 2012 (undefined)
Primary Completion Date
August 2014 (Actual)
Study Completion Date
September 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rigshospitalet, Denmark
Collaborators
Glostrup University Hospital, Copenhagen

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The analgesic effect of dexamethasone is not well described, but studies have shown that dexamethasone can be a safe part of a multimodal analgesic strategy after surgery. Our purpose is to investigate if dexamethasone in combination with paracetamol and ibuprofen has an increased analgesic effect compared to paracetamol and ibuprofen alone, on postoperative pain after spine surgery. Our hypothesis is that dexamethasone can reduce postoperative pain and reduce opioidconsumption and side effects compared to placebo.
Detailed Description
The analgesic effect of dexamethasone is not well described, but studies have shown that an intermediate dosis of dexamethasone (0.11-0.2 mg/kg) can be a safe part of a multimodal analgesic strategy after surgery. Dexamethasone has an opioid-sparing effect and reduces pain during rest and mobilisation. Our purpose is to investigate if dexamethasone in combination with paracetamol and ibuprofen has an increased analgesic effect compared to paracetamol and ibuprofen alone, on postoperative pain after herniated disk surgery. Our hypothesis is that dexamethasone can reduce postoperative pain and reduce opioidconsumption and side effects compared to placebo.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain
Keywords
Pain, Analgesia, Postoperative, Dexamethasone, Spine surgery

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
160 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Dexamethasone
Arm Type
Active Comparator
Arm Description
Intravenous administration of dexamethasone 16 mg (concentration 4 mg/ml, volume 4 ml) immediately after endotracheal intubation Morphine. Patient controlled intravenous morphine (PCA-pump), bolus 2.5 mg, lock-out-time 10 minutes. Concentration : Morphin 1 mg/ml. Zofran 4 mg iv in case of moderate to severe nausea, supplemented by Zofran 1 mg iv if needed Tablet Paracetamol 1 g orally and tablet Ibuprofen 400 mg orally. Both 1 hour preoperatively and every 6 hours after extubation time during the first 48 hours.
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Intravenous administration of isotonic sodium chloride (concentration 9 mg/ml, volume 4 ml) immediately after endotracheal intubation Morphine. Patient controlled intravenous morphine (PCA-pump), bolus 2.5 mg, lock-out-time 10 minutes. Concentration : Morphin 1 mg/ml. Zofran 4 mg iv in case of moderate to severe nausea, supplemented by Zofran 1 mg iv if needed Tablet Paracetamol 1 g orally and tablet Ibuprofen 400 mg orally. Both 1 hour preoperatively and every 6 hours after extubation time during the first 48 hours.
Intervention Type
Drug
Intervention Name(s)
Dexamethasone
Intervention Description
Intravenous administration of dexamethasone 16 mg (concentration 4 mg/ml, volume 4 ml) immediately after endotracheal intubation
Intervention Type
Other
Intervention Name(s)
Placebo
Intervention Description
Intravenous administration of isotonic sodium chloride (concentration 9 mg/ml, volume 4 ml) immediately after endotracheal intubation
Intervention Type
Drug
Intervention Name(s)
Morphine
Intervention Description
Morphine. Patient controlled intravenous morphine (PCA-pump), bolus 2.5 mg, lock-out-time 10 minutes. Concentration : Morphin 1 mg/ml.
Intervention Type
Drug
Intervention Name(s)
Zofran
Intervention Description
Zofran 4 mg iv in case of moderate to severe nausea, supplemented by Zofran 1 mg iv if needed
Intervention Type
Drug
Intervention Name(s)
Paracetamol
Intervention Description
Tablet Paracetamol 1 g orally, 1 hour preoperatively and every 6 hours after extubation time during the first 48 hours.
Intervention Type
Drug
Intervention Name(s)
Ibuprofen
Intervention Description
Tablet Ibuprofen 400 mg orally, 1 hour preoperatively and every 6 hours after extubation time during the first 48 hours.
Primary Outcome Measure Information:
Title
Painscore during mobilization
Description
Painscore during active mobilization (VAS scale) defined by a standarized movement from recumbent position to sitting on the bedside at time 2, 4, 8, 12 and 24 hours, calculated as area under curve (AUC) from 2-24 hours after extubation time.
Time Frame
2-24 hours after extubation time.
Secondary Outcome Measure Information:
Title
Painscore during rest
Description
Painscore during rest (VAS scale) at time 2, 4, 8, 12 and 24 hours, calculated as area under curve (AUC) from 2-24 hours after extubation time.
Time Frame
2-24 hours after extubation time
Title
Morphine consumption
Description
Total morphine consumption 0-24 hours after extubation time, administered as patient controlled analgesia (PCA, bolus 2.5 mg, lockout 10 minutes).
Time Frame
0-24 hours after extubation time.
Title
Painscore during rest and mobilization
Description
Painscore during rest and during active mobilization (VAS scale) at time 48 hours after extubation time.
Time Frame
48 hours after extubation time
Title
Degree of nausea
Description
Degree of nausea 2, 4, 8, 12, 24 and 48 hours after extubation time
Time Frame
2, 4, 8, 12, 24 and 48 hours after extubation time
Title
Incidence of vomiting
Description
Total number of vomits 0-2, 2-4, 4-8, 8-12, 12-24 and 24-48 hours after extubation time.
Time Frame
0-2, 2-4, 4-8, 8-12, 12-24 and 24-48 hours after extubation time.
Title
Zofran consumption
Description
Consumption of Zofran (milligram) 0-24 and 24-48 hours after extubation time.
Time Frame
0-24 and 24-48 hours after extubation time.
Title
Degree of sedation
Description
Degree of sedation 2, 4, 8, 12, 24 and 48 hours after extubation time.
Time Frame
2, 4, 8, 12, 24 and 48 hours after extubation time.
Title
Quality of sleep
Description
Quality of sleep 24 hours after extubation time.
Time Frame
24 hours after extubation time.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients undergoing lumbar disc surgery in general anaesthesia. Patients who have given their written consent to participate and understand the contents of the protocol. ASA 1-3. BMI > 18 og < 40. Fertile women need a negative HCG urine test. Exclusion Criteria: Patients who cannot cooperate to the study. Patients who do not speak and/or understand Danish. Fertile women with a positive HCG urine test. Allergy to the drugs used in the trial. Alcohol or medicine abuse, assessed by investigator. Patients who have had spine surgery before. Daily use of strong opioids (morphine, ketobemidone, oxynorm, methadone, fentanyl) Daily oral steroid treatment.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rikke Soennichsen, MD
Organizational Affiliation
Glostrup University Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Joergen B Dahl, MD
Organizational Affiliation
Rigshospitalet, Denmark
Official's Role
Study Chair
Facility Information:
Facility Name
Glostrup University Hospital
City
Glostrup
ZIP/Postal Code
2600
Country
Denmark

12. IPD Sharing Statement

Citations:
PubMed Identifier
27852230
Citation
Nielsen RV, Fomsgaard J, Mathiesen O, Dahl JB. The effect of preoperative dexamethasone on pain 1 year after lumbar disc surgery: a follow-up study. BMC Anesthesiol. 2016 Nov 16;16(1):112. doi: 10.1186/s12871-016-0277-z.
Results Reference
derived
PubMed Identifier
26270586
Citation
Nielsen RV, Siegel H, Fomsgaard JS, Andersen JDH, Martusevicius R, Mathiesen O, Dahl JB. Preoperative dexamethasone reduces acute but not sustained pain after lumbar disk surgery: a randomized, blinded, placebo-controlled trial. Pain. 2015 Dec;156(12):2538-2544. doi: 10.1097/j.pain.0000000000000326.
Results Reference
derived

Learn more about this trial

The Effect of Dexamethasone in Combination With Paracetamol and Ibuprofen on Postoperative Pain After Spine Surgery

We'll reach out to this number within 24 hrs